المؤلفون: M. Gershenson, David, Miller, Austin, E Brady, William, Paul, James, Carty, Karen, Rodgers, William, Millan, David, L Coleman, Robert, N Moore, Kathleen, Banerjee, Susana, Connolly, Kate, Alvarez Secord, Angeles, M O'Malley, David, Dorigo, Oliver, Gaillard, Stephanie, Gabra, Hani, Slomovitz, Brian, Hanjani, Parviz, Farley, John, Churchman, Michael, Ewing, Ailith, Hollis, Robb, Herrington, C Simon, Q Huang, Helen, B Wenzel, Lari, Gourley, Charlie

المصدر: M. Gershenson, D, Miller, A, E Brady, W, Paul, J, Carty, K, Rodgers, W, Millan, D, L Coleman, R, N Moore, K, Banerjee, S, Connolly, K, Alvarez Secord, A, M O'Malley, D, Dorigo, O, Gaillard, S, Gabra, H, Slomovitz, B, Hanjani, P, Farley, J, Churchman, M, Ewing, A, Hollis, R, Herrington, C S, Q Huang, H, B Wenzel, L & Gourley, C 2022, ' Trametinib versus standard of care in patients with recurrent low-grade serous ovarian cancer (GOG 281/LOGS): a randomised, open-label phase 2/3 trial ', The Lancet, vol. 399, no. 10324, pp. 541-553 . https://doi.org/10.1016/S0140-6736(21)02175-9

مصطلحات موضوعية: Adult, Pyridones/administration & dosage, Administration, Oral, Ovarian Neoplasms/drug therapy, Standard of Care, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Progression-Free Survival, United Kingdom, United States, Treatment Outcome, Paclitaxel/administration & dosage, Humans, Female, MAP Kinase Kinase 1/metabolism, Pyrimidinones/administration & dosage, Neoplasm Grading, Neoplasm Recurrence, Local/pathology, Aged, Carcinoma, Ovarian Epithelial/drug therapy

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3094::10daf3830e8817199b8469c4d2ece72c
https://hdl.handle.net/20.500.11820/745251c7-7e6d-4cf1-9129-3a76f1637764

المؤلفون: Van Gorp, Toon Mirza, Mansoor Raza Lortholary, Alain Cibula, David Walther, Axel Savarese, Antonella Barretina-Ginesta, Maria Pilar Ortac, Firat Papadimitriou, Christos Bodnar, Lubomir Lai, Chyong-Huey Korach, Jacob Marth, Christian and Hasegawa, Kosei Xie, Xing Barber, Emma L. Coleman, Robert L. and Keefe, Stephen Michael Orlowski, Robert Slomovitz, Brian

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______2127::c2d929310ab288ca865e43337ab4c6c1
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3196669

المؤلفون: Alpa M. Nick, Robert L Coleman Robert, yunfei wen, Gary E. Gallick, Anil K. Sood, Gabriel Lopez-Berestein, Mien Chie Hung

المصدر: Clinical Cancer Research. 25:AP21-AP21

مصطلحات موضوعية: Cancer Research, Oncology, business.industry, Anti angiogenic, Cancer research, Medicine, business, Adaptive resistance, Ovarian cancer, medicine.disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::e57a5295779b0c5b976da39bd9adf169
https://doi.org/10.1158/1557-3265.ovcasymp18-ap21

المؤلفون: Thanapprapasr, Duangmani, Hu, Wei, K Sood, Anil, L Coleman, Robert

المصدر: Current Pharmaceutical Design ; volume 18, issue 19, page 2713-2719 ; ISSN 1381-6128

الاتاحة: http://dx.doi.org/10.2174/138161212800626201
http://eurekaselect.com/article/download/97859

المؤلفون: Vlahou, Antonia, O. Schorge, John, W. Gregory, Betsy, L. Coleman, Robert

المصدر: Journal of Biomedicine and Biotechnology; 2003, Vol. 2003 Issue: 1

المؤلفون: Giuseppe Caruso, Robert L Coleman, Giovanni Aletti, Francesco Multinu, Andrea Botticelli, Innocenza Palaia, William Cliby, Nicoletta Colombo

المساهمون: Caruso, Giuseppe, L Coleman, Robert, Aletti, Giovanni, Multinu, Francesco, Botticelli, Andrea, Palaia, Innocenza, Cliby, William, Colombo, Nicoletta

مصطلحات موضوعية: BRCA1 Protein, BRCA2 Protein, Homologous recombination, Ovarian Cancer, Quality of Life (PRO)/Palliative Care

Relation: info:eu-repo/semantics/altIdentifier/pmid/37597852; info:eu-repo/semantics/altIdentifier/wos/WOS:001073561400016; volume:33; issue:9; firstpage:1448; lastpage:1457; numberofpages:10; journal:INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER; https://hdl.handle.net/11573/1690194; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85169847708

الاتاحة: https://hdl.handle.net/11573/1690194
https://doi.org/10.1136/ijgc-2023-004740